Sleep

A roundup of the latest news in sleep research reported across MJH Life Sciences™.

Jazz Pharmaceuticals’ Xywav oral solution is the first treatment to be approved for adults with idiopathic hypersomnia.

Results of the phase 3 REST-ON study exhibited significant improvement in patients with narcolepsy treated with once-nightly sodium oxybate, FT218, versus placebo.

Relaxed social and professional constraints brought on by pandemic-related lockdowns benefitted the sleep schedules of patients with central hypersomnias.

People with high risk of obstructive sleep apnea presented with significant changes in key arteries indicative of accelerated vascular aging, a known contributor to cardiovascular disease (CVD).

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor, Neurology, Albert Einstein College of Medicine, speaks about common misconceptions within the treatment of narcolepsy-related excessive daytime sleepiness, and how combination therapy may play a role.

Higher physical activity and less time spent sitting and watching TV was associated with a significantly lower risk of developing obstructive sleep apnea.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisenger, speaks on early data findings of the Wake Up and Learn program which suggested a greater risk of sleep pathology among adolescents than typically observed.

The Academy of Sleep Medicine and the Sleep Research Society issued guiding principles for employers on designing optimal work shift durations in the workplace, which address risk factors, countermeasures, and shared decision-making implications.

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, addresses the treatment of narcolepsy in recent years.

The FDA issued a 510(k) clearance for the artificial intelligence software platform EnsoSleep, expanding its capabilities in assessing patients with chronic respiratory and cardiac conditions, as well as in pediatric populations ages 13 and above.

Children exposed to environmental stressors known to impair sleep exhibited improved sleep duration by more than 1 hour each night after undergoing a mindfulness training intervention program, with rapid-eye movement sleep improving as well.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist at Geisinger, discusses biologic, lifestyle, and pandemic-related factors associated with poor sleep quality in adolescents.

Compared with participants with high physical activity and healthy sleep, those with no moderate-to-vigorous physical activity exhibited higher risks of all-cause, total cardiovascular, and total cancer mortality.

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor, Neurology, Albert Einstein College of Medicine, discusses diagnostic components of idiopathic hypersomnia and emerging methods of treatment.

Children whose sleep apnea persist into adolescence have a 3-fold increased risk of high blood pressure and face an elevated risk of heart disease.

These review results were mixed on the use of immunotherapy to treat narcolepsy, with benefits typically being temporary.

Individuals with insomnia had 1.41 times the risk of developing hypertension, compared with people without the sleep disorder.

Many patients experience excessive daytime sleepiness (EDS) despite treatment for obstructive sleep apnea (OSA) and may benefit from wake-promoting drugs.

The new report, based on more than 80,000 health records, suggests positive airflow pressure therapy can reduce a patient’s risk of infection.

Long-term use of prescription sleep medications by middle-aged women provides no benefit, a new study says.

People who suffer from shift work sleep disorder face the highest risk of a car crash, although sleep apnea and insomnia also heighten a person’s risk.

Sleep disorders were found to be associated with significantly higher rates of health care utilization and cost, accounting for $94.9 billion in costs each year in the United States.

The group-based Sleep Apnea Management clinic at Cleveland Clinic's Sleep Disorders Center increased criteria-met adherence to positive airway pressure (PAP) therapy by 20% in patients with obstructive sleep apnea (OSA).

For each hour that an employee’s work schedule deviated from their natural body clock, their odds of having high cardiovascular risk increased by 31%.